Regulation of prostaglandin F-2 alpha, against beta amyloid clearance and its inflammation induction through LXR/RXR heterodimer antagonism in microglia | |
Zhuang, Jingjing2; Zhang, Haikun2; Zhou, Rong2; Chen, Lili1; Chen, Jing1; Shen, Xu1,2 | |
刊名 | PROSTAGLANDINS & OTHER LIPID MEDIATORS |
2013-10 | |
卷号 | 106页码:45-52 |
关键词 | Prostaglandin F-2 alpha Alzheimer's disease A beta clearance Inflammation Microglia |
ISSN号 | 1098-8823 |
DOI | 10.1016/j.prostaglandins.2013.09.002 |
文献子类 | Article |
英文摘要 | Alzheimer's disease (AD) is characterized by extracellular deposit of beta-amyloid (A beta) and accumulation of intracellular neurofibrillary tangles in the brain. Prostaglandin F-2 alpha, (PGF(2 alpha)) is one of the major metabolites of arachidonic acid (AA), and plays essential roles in a series of key physiological processes like luteolysis and parturition. Additionally, PGF(2 alpha) is also involved in the regulation of chronic and acute inflammation processes. Recent clinical studies have revealed the high content of PGE(2 alpha) metabolite, 15-keto-dihydro-PGF(2 alpha) in AD patients, implying the activation of in vivo PGF(2 alpha) biosynthesis. However, the mechanism underlying the involvement of PGF(2 alpha) in the progression of AD still remains unclear. Here we discovered that PGF(2 alpha) selectively antagonized LXR (liver X receptors)/RXR (retinoid X receptor alpha) and RXR/RXR dimers. Cell based assays indicated that PGF(2 alpha) effectively antagonized the activation of LXR agonist (t0901317) on A beta clearance via inhibiting apolipoprotein E (apoE) expression, and cell apoptosis alleviation by accelerating inflammatory response to A beta or Lipopolysaccharide (LPS) in microglia. Therefore, our current findings have addressed the potential association of PGF(2 alpha) with AD progression, and highlighted that inhibition of PGF(2 alpha) biosynthesis might be a useful therapeutic strategy against AD. (C) 2013 Elsevier Inc. All rights reserved. |
资助项目 | National Science & Technology Major Project "Key New Drug Creation. and Manufacturing Program"[2012ZX09103101-018] ; National Science & Technology Major Project "Key New Drug Creation. and Manufacturing Program"[2012ZX09301001-004] ; State Key Program of Basic Research of China[2010CB912501] ; Science Foundation of Shanghai[12431900300] |
WOS关键词 | LIVER-X-RECEPTORS ; CYTOKINE-MEDIATED INFLAMMATION ; ALZHEIMERS-DISEASE ; MOLECULAR-MECHANISMS ; ELDERLY POPULATION ; SIGNALING PATHWAY ; OXIDATIVE STRESS ; A-BETA ; BRAIN ; LXR |
WOS研究方向 | Biochemistry & Molecular Biology ; Cell Biology |
语种 | 英语 |
出版者 | ELSEVIER SCIENCE INC |
WOS记录号 | WOS:000328720000007 |
内容类型 | 期刊论文 |
源URL | [http://119.78.100.183/handle/2S10ELR8/277429] |
专题 | 药物安全性评价中心 药理学第三研究室 |
通讯作者 | Chen, Jing |
作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, Key Lab Receptor Res, Shanghai 201203, Peoples R China 2.E China Univ Sci & Technol, Sch Pharm, Shanghai 200237, Peoples R China; |
推荐引用方式 GB/T 7714 | Zhuang, Jingjing,Zhang, Haikun,Zhou, Rong,et al. Regulation of prostaglandin F-2 alpha, against beta amyloid clearance and its inflammation induction through LXR/RXR heterodimer antagonism in microglia[J]. PROSTAGLANDINS & OTHER LIPID MEDIATORS,2013,106:45-52. |
APA | Zhuang, Jingjing,Zhang, Haikun,Zhou, Rong,Chen, Lili,Chen, Jing,&Shen, Xu.(2013).Regulation of prostaglandin F-2 alpha, against beta amyloid clearance and its inflammation induction through LXR/RXR heterodimer antagonism in microglia.PROSTAGLANDINS & OTHER LIPID MEDIATORS,106,45-52. |
MLA | Zhuang, Jingjing,et al."Regulation of prostaglandin F-2 alpha, against beta amyloid clearance and its inflammation induction through LXR/RXR heterodimer antagonism in microglia".PROSTAGLANDINS & OTHER LIPID MEDIATORS 106(2013):45-52. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论